What sector does Pharmarise Holdings Corporation belong to?

Pharmarise Holdings Corporation operates in the Consumer Discretionary sector, specifically the Retail Trade industry, and is listed on the US markets.

What is the current share price of 2796?

As of the latest available quote, 2796 traded at ¥507.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 2796?

Pharmarise Holdings Corporation has a price-to-earnings (P/E) ratio of about 52.65. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 2796?

The market capitalisation of Pharmarise Holdings Corporation is approximately ¥5.77B.

Is Pharmarise Holdings Corporation profitable?

For its latest reported financial year, Pharmarise Holdings Corporation recorded a net profit margin of about 0.16%.

Does 2796 pay a dividend?

Pharmarise Holdings Corporation currently has a dividend yield of about 2.77%.

What is the return on equity (ROE) of 2796?

Pharmarise Holdings Corporation has a return on equity (ROE) of about 1.70%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 2796?

Over the past 52 weeks, 2796 has traded between a low of ¥471.00 and a high of ¥558.00.

Pharmarise Holdings Corporation

2796 TSE Consumer Discretionary Retail Trade

TSE Standard

¥507.00

+0.40%

Delayed · cached 15 min

Fair value analysis

2796

Pharmarise Holdings Corporation

¥507.00

Close used for this calculation

¥228.50Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

31/100

Profitability14/25

Returns10/25

Balance Sheet2/25

Efficiency5/25

Growth15/25

Weak

Quality radar

Consensus fair value

¥228.50

Above FV

▼ -54.9% against the close used

Model range ¥97.94 – ¥360.22

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥97.94Fair value¥228.50Bull¥360.22

FairClose

52-week traded range

52W low ¥472.0052W high ¥547.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Pharmarise Holdings Corporation closed at ¥507.00, 121.9% above the consensus fair value of ¥228.50 drawn from 9 valuation models.

Financial DNA score 31/100 — Weak. P/E of 50.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

¥187.61

-63.0%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

¥360.22

-29.0%

√(22.5 × EPS × BVPS)

EPS=10.01, BVPS=576.14 · outside Graham range (P/E 50.7, P/B 0.9) — asset-light, treat as a rough floor

P/E Fair Value

¥200.20

-60.5%

EPS × 20x (sector P/E)

EPS=10.01, Sector P/E=20x

Peter Lynch (PEG)

¥232.03

-54.2%

EPS × Growth% (PEG = 1 is fair)

EPS=10.01, g=23.2%

EV/EBITDA

¥317.51

-37.4%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=1.76B

Dividend Discount (DDM)

¥178.41

-64.8%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=13.99, r=10%, g=2%

Book Value (P/B)

¥97.94

-80.7%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=576.14, ROE=1.7%, g=3%, r=10%

Reverse DCF

¥507.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 19.7% | Historical: -23.2%

Margin of Safety

¥187.01

-63.1%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=249.34, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer